Lip GY - Search Results

1

Clinical and Economic Implications of Apixaban Versus Aspirin in the Low-Risk Nonvalvular Atrial Fibrillation Patients.

Lip GY, Lanitis T, Mardekian J, Kongnakorn T, Phatak H, Dorian P. Lip GY, et al. Stroke. 2015 Oct;46(10):2830-7. doi: 10.1161/STROKEAHA.115.009995. Epub 2015 Aug 27. Stroke. 2015. PMID: 26316345 Clinical Trial.

2

Ethnic differences in patient perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham Atrial Fibrillation Project.

Lip GY, Kamath S, Jafri M, Mohammed A, Bareford D. Lip GY, et al. Stroke. 2002 Jan;33(1):238-42. doi: 10.1161/hs0102.101817. Stroke. 2002. PMID: 11779916

3

Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation.

Kamath S, Blann AD, Caine GJ, Gurney D, Chin BS, Lip GY. Kamath S, et al. Among authors: lip gy. Stroke. 2002 May;33(5):1237-42. doi: 10.1161/01.str.0000013739.82306.7f. Stroke. 2002. PMID: 11988597 Clinical Trial.

4

Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor?

Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY. Chung NA, et al. Among authors: lip gy. Stroke. 2002 Sep;33(9):2187-91. doi: 10.1161/01.str.0000023889.84649.3d. Stroke. 2002. PMID: 12215585 Clinical Trial.

5

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: lip gy. Circulation. 2002 Oct 8;106(15):1962-7. doi: 10.1161/01.cir.0000033220.97592.9a. Circulation. 2002. PMID: 12370220 Clinical Trial.

6

Antithrombotic therapy for atrial fibrillation.

Lip GY, Hart RG, Conway DS. Lip GY, et al. BMJ. 2002 Nov 2;325(7371):1022-5. doi: 10.1136/bmj.325.7371.1022. BMJ. 2002. PMID: 12411366 Free PMC article. Review. No abstract available.

7

A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy.

Kamath S, Blann AD, Chin BS, Lanza F, Aleil B, Cazenave JP, Lip GY. Kamath S, et al. Among authors: lip gy. Eur Heart J. 2002 Nov;23(22):1788-95. doi: 10.1053/euhj.2002.3259. Eur Heart J. 2002. PMID: 12419299

8

Atrial fibrillation and the prothrombotic state in the elderly: the Rotterdam Study.

Conway DS, Heeringa J, Van Der Kuip DA, Chin BS, Hofman A, Witteman JC, Lip GY. Conway DS, et al. Among authors: lip gy. Stroke. 2003 Feb;34(2):413-7. doi: 10.1161/01.str.0000051728.85133.32. Stroke. 2003. PMID: 12574552

9

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Marín F, Roldán V, Climent V, Garcia A, Marco P, Lip GY. Marín F, et al. Among authors: lip gy. Stroke. 2003 May;34(5):1181-6. doi: 10.1161/01.STR.0000065431.76788.D9. Epub 2003 Mar 27. Stroke. 2003. PMID: 12663879

10

Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Conway DS, et al. Among authors: lip gy. Circulation. 2003 Jul 1;107(25):3141-5. doi: 10.1161/01.CIR.0000077912.12202.FC. Epub 2003 Jun 9. Circulation. 2003. PMID: 12796127 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,112 results

Search Page

Filters